Latest Articles

Kerry Taylor-Smith explores the latest advances in synthetic biology, from the development of new agricultural biotechnology tools to therapeutics and diagnostics.

Technology Networks invited chief editor at Nature Biotechnology, Barbara Cheifet, to an Ask Me Anything session to answer questions about the biggest challenges in scientific publishing and how to get work published in high-ranking journals.

The impetus to demonstrate regulatory compliance to ensure their products are safe for human consumption is an imperative for pharmaceutical and biotechnology organizations.

Using data provided by Intercontinental Exchange, My Green Lab has produced a report providing key insights into the current state of the sector’s carbon emissions. James Connelly highlights some of the key findings and their significance.

This article explores how biopharmaceutical organizations seeking to remain competitive must adopt innovations, like cell-free long DNA synthesis, to unleash the potential of synthetic biology and accelerate therapeutic development across all facets of genetic medicine.

The term cell therapy refers to the transfer of cellular materials into a patient for therapeutic purposes. Here, we look to introduce the different types of cell therapies, including stem-cell and non-stem cell-based unicellular therapies as well as multicellular therapies.

Two-dimensional liquid chromatography (2D-LC) offers extra separation power for complex and challenging samples and now has an important place in industry as well academia thanks to important advances. But this is by no means the end of the story.

This article will explore the role of the immune system and immune evasion in cancer and will discuss how the immune system can be exploited therapeutically and the recent advances in cancer immunotherapy.

A diverse array of biological medicines are now used to prevent and treat a wide range of illnesses. This article will discuss the development of cell lines in biopharma and will touch on key considerations, such as future manufacturability.

Host cell proteins can prove problematic for the development of novel biopharmaceuticals. This article will highlight some of the latest advances in host cell analysis strategies and how they are being implemented.